A carregar...
Rapamycin and rapalogs for tuberous sclerosis complex
BACKGROUND: Previous studies have shown potential benefits of rapamycin or rapalogs for treating people with tuberous sclerosis complex. Although everolimus (a rapalog) is currently approved by the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency) for tuberous sclerosis...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2016
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6458010/ https://ncbi.nlm.nih.gov/pubmed/27409709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011272.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|